SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-18-003328
Filing Date
2018-04-26
Accepted
2018-04-26 16:07:03
Documents
2
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 16857
2 GRAPHIC defa14ag001.gif GRAPHIC 83809
  Complete submission text file 0001558370-18-003328.txt   133338
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38150 | Film No.: 18778551
SIC: 2834 Pharmaceutical Preparations